These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15907584)

  • 21. Inflammation-triggered local drug release ameliorates colitis by inhibiting dendritic cell migration and Th1/Th17 differentiation.
    Regmi S; Pathak S; Nepal MR; Shrestha P; Park J; Kim JO; Yong CS; Choi DY; Chang JH; Jeong TC; Orive G; Yook S; Jeong JH
    J Control Release; 2019 Dec; 316():138-149. PubMed ID: 31689461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis.
    Naeem M; Lee J; Oshi MA; Cao J; Hlaing SP; Im E; Jung Y; Yoo JW
    Acta Biomater; 2020 Oct; 116():368-382. PubMed ID: 32937207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
    Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
    J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate.
    Mo Y; Lim LY
    J Control Release; 2005 Sep; 107(1):30-42. PubMed ID: 16051391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparticulate formulation approach to colon specific drug delivery: current perspectives.
    Asghar LF; Chandran S
    J Pharm Pharm Sci; 2006; 9(3):327-38. PubMed ID: 17207416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
    El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
    Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering.
    Yilgor P; Tuzlakoglu K; Reis RL; Hasirci N; Hasirci V
    Biomaterials; 2009 Jul; 30(21):3551-9. PubMed ID: 19361857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.
    Devalapally H; Shenoy D; Little S; Langer R; Amiji M
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver targeting and the delayed drug release of the nanoparticles of adriamycin polybutylcyanoacrylate in mice.
    Shen LF; Zhang YD; Shen HJ; Zeng S; Wang X; Wang C; Le Y; Shen H
    Chin Med J (Engl); 2006 Aug; 119(15):1287-93. PubMed ID: 16919188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
    Yang ZQ; Xu J; Pan P; Zhang XN
    Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(lactic-co-glycolic acid) nanospheres and microspheres for short- and long-term delivery of bioactive ciliary neurotrophic factor.
    Nkansah MK; Tzeng SY; Holdt AM; Lavik EB
    Biotechnol Bioeng; 2008 Aug; 100(5):1010-9. PubMed ID: 18431801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of local tumor growth with paclitaxel-loaded microspheres.
    Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
    Kim JH; Taluja A; Knutson K; Han Bae Y
    J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellulose acetate butyrate-pH/thermosensitive polymer microcapsules containing aminated poly(vinyl alcohol) microspheres for oral administration of DNA.
    Fundueanu G; Constantin M; Bortolotti F; Cortesi R; Ascenzi P; Menegatti E
    Eur J Pharm Biopharm; 2007 Apr; 66(1):11-20. PubMed ID: 17085025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
    Krishnamachari Y; Madan P; Lin S
    Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).
    Bhavsar MD; Amiji MM
    J Control Release; 2007 Jun; 119(3):339-48. PubMed ID: 17475358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
    Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
    Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.